Biotech · Private company
CanariaBio Inc.
Track this companyFree. Adds CanariaBio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CarboplatinPhase 3 · Carcinoma, Ovarian EpithelialClinicalTrials.gov · fetched Nov 12, 2026
- OregovomabPhase 3 · Carcinoma, Ovarian EpithelialClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 3 · Carcinoma, Ovarian EpithelialClinicalTrials.gov · fetched Nov 12, 2026
- NiraparibPhase 2 · Recurrent Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- OregovomabPhase 2 · Recurrent Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- OregovomabPhase 1 · Cancer of OvaryClinicalTrials.gov · fetched Nov 12, 2026
- Poly ICLCPhase 1 · Cancer of OvaryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 25, 2022ClinicalTrials.gov NCT05335993 · fetched Nov 12, 2026
- Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking SurgeryPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 25, 2020ClinicalTrials.gov NCT04498117 · fetched Nov 12, 2026
- The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian CancerPHASE1 · TERMINATED · started May 30, 2017ClinicalTrials.gov NCT03162562 · fetched Nov 12, 2026